updat model forecast organ sale growth
exclud impact new account standard reduc
report sale growth sale came ahead vs
led higher endoscopi neurotechnolog oper margin
expans exclud impact line think y/i
greater sg leverag offset lower gross margin mako placement
sale growth ep guidanc rang up
respect fx expect favor ep hip/kne
market growth far premium market consist
hip/knee/spin market hip/kne market growth far
versu manag point season rather underli
demand chang price trend consist spine manag note
continu challeng us market well low double-digit price declin across
matur core product slightli experienc
mako highlight system place compar current
system upgrad total knee applic reach track mostli
complet system place competit account current
mako util us hospit long term compani believ half
us hospit potenti candid robot system
guidanc rais sale ep outlook account
strong continu favor impact fx organ sale growth
includ posit fx vs previous guid
oper margin expans target remain oper
tax rate remain tax reform
estim sale rise underli sale growth
higher endoscopi neurotechnolog sale ep rise
higher sale lower interest expens higher
estim price target move
medic devic compani
found headquart
kalamazoo mi compani
orthopaed medsurg equip
analyst certif import disclosur see disclosur
underli revenu growth led neurotech stent
retriev knee iendoscopi trauma/extrem
oper margin ex-asc despit
assum entellu dilut fx contribut ep
rate perform price target balanc
sheet divers growth opportun solid execut
posit rate share perform valuat trade
ep estim versu peer
on-going launch triathlon knee mako robot
mako placement acceler ahead expect wake
better expect margin leverag
better us capital-expenditure environ lead medsurg expect
slowdown hospit capit spend slow medsurg segment
greater expect price pressur
competit product launch knee impact growth more/soon
expect
price target impli price-to-earnings multipl ep higher peer group averag owe
faster near-term ep growth
risk price target includ wors expect price pressur key market tough competit slowdown hospit
neurotechnolog spine
neurotechnolog spine
stock price compani mention report
